Danone Research & Innovation

What Danone Research & Innovation does

Danone Research & Innovation (legal entity: DANONE GLOBAL RESEARCH & INNOVATION CENTER SAS) is the centralized corporate R&D function of Danone S.A., headquartered in Gif-sur-Yvette, France, within the Paris-Saclay research cluster. The division serves as Danone's internal innovation engine, generating the scientific evidence, proprietary strains, clinical data, and product formulations that feed the parent's portfolio across Essential Dairy and Plant-Based Products, Waters, and Specialized Nutrition — including flagship consumer brands in infant nutrition (Aptamil, Nutrilon), fermented dairy (Actimel, Danio), and medical nutrition.

The division's research platform is anchored in four core domains: biotics and probiotic strain development, gut microbiome science, early life and maternal nutrition, and specialized/clinical nutrition. Its technology stack combines a proprietary fermentation and biotics strain library with in vitro gut simulation models (developed in partnership with TNO), computer-vision-enabled consumer health applications (Stool Tracker, Iron Tracker, Growth Tracker), and computational biology pipelines used for personalized nutrition research. The unit reports a research footprint of roughly 2,000 experts and an IP portfolio exceeding 5,000 patents, publishing 200+ peer-reviewed papers annually.

As a captive corporate function, the unit does not generate external revenue. It is funded through Danone S.A.'s group R&D allocation and operates as a cost center whose outputs are internalized by Danone's brand businesses. Its economic significance is therefore measured by the speed, novelty, and defensibility of the IP and evidence it produces, rather than by top-line revenue. Go-to-market is effectively the parent company's existing global distribution and brand infrastructure.

Name

Danone Research & Innovation

Legal name

DANONE GLOBAL RESEARCH & INNOVATION CENTER SAS

Website

https://danoneresearch.com

Company type

Private

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Danone Research & Innovation is Danone S.A.'s centralized R&D division, generating proprietary biotics, gut microbiome, early life nutrition, and specialized nutrition science for the parent's dairy, plant-based, and medical nutrition brands.

Ownership category

akta.pro rank

Product category

Food and Nutrition Research and Innovation

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

akta.pro secondary industries

Condition-Specific Bioactives (Glucosamine/Chondroitin, Plant Sterols, Melatonin, Lutein/Zeaxanthin) (AFAJAKAK), Specialty & Functional Packaged Foods (Gluten-Free, Keto, Organic, Medical/Allergen-Friendly) (CRADAAAI)

Keywords

• Nutrition research
• Biotics ingredients
• Digital health tools
• Gut microbiome science
• Food science innovation

Headquarters

HQ city

Gif-sur-Yvette

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Product Development for Danone Commercial Brands: Danone R&I drives revenue by developing superior, evidence-based nutritional products across Danone's categories (dairy, plant-based, specialized nutrition, waters) that are commercialized through Danone's global sales and distribution infrastructure.
2. Scientific Publications and Congress Abstracts: Over 200 publications and congress abstracts annually contributing to Danone's scientific credibility and product differentiation in the market.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Danone Research & Innovation operates as Danone S.A.'s internal science and innovation division, conducting nutrition, gut microbiome, and digital health research to develop evidence-based food, beverage, and specialized nutrition products. It produces proprietary probiotic, prebiotic, synbiotic, and postbiotic ingredients; AI-powered digital health applications (Stool Tracker, Iron Tracker, Growth Tracker); and specialized hypoallergenic infant formulas, all funneled into Danone's commercial brand portfolio.

Product overview

Danone Research & Innovation operates as a research and innovation division focused on nutrition science, offering a portfolio of digital health tools, biotic ingredients (probiotics, prebiotics, synbiotics, postbiotics), specialized nutritional products, and foundational research in gut health, immunity, and protein science. The digital health offerings include the Stool Tracker, Iron Tracker, and Growth Tracker applications. The biotics portfolio centers on four categories of gut health ingredients, while specialized nutrition includes hypoallergenic formulas for infants with cow's milk allergy. The company also researches and develops protein products using dairy, plant-based, and biotechnology-derived sources.

Differentiator

Problem solved

Functional benefit

Brands

• OneBiome: Gut microbiome research initiative and platform
• Iron Up!
• Stool Tracker
• Iron Tracker
• Growth Tracker

Products and services

• Stool Tracker AI-powered smartphone application that helps parents assess their baby's stool consistency and color using image recognition. Classifies stool according to the Brussels Infant and Toddler Stool Scale (BITSS) and provides science-based insights in real-time. Active in over 40 countries.
• Iron Tracker Non-invasive screening tool for iron deficiency anemia that measures hemoglobin levels and iron intake. Uses a device from a medical device company partner combined with an iron intake questionnaire. Deployed across Asia, Africa, and the Middle East with over 2 million children screened to date.
• Growth Tracker Application that helps measure children's length and tracks growth indicators like height and weight over time. Developed in partnership with KK Women's and Children's Hospital (KKH) Singapore to help parents and clinicians monitor children's development.
• Probiotics Beneficial live bacteria that aid digestion and strengthen the immune system. Danone has been developing probiotic-enriched products since the 1980s, including exclusive strains like Lactobacillus casei that help reduce occurrence and duration of common infectious diseases.
• Prebiotics (scGOS/lcFOS blend) Non-digestible fibers that feed beneficial bacteria in the intestine. Danone's unique blend of prebiotics (scGOS & lcFOS) faithfully reproduces oligosaccharides found in human milk and helps alleviate allergy symptoms in infants.
• Synbiotics Combinations of probiotics and prebiotics designed to act synergistically to improve intestinal health. Danone's synbiotic formulas integrate specific strains such as Bifidobacterium breve to help restore intestinal microbiota in infants.
• Postbiotics Inactive bacterial components or metabolites that continue to have health benefits by acting on intestinal function. Part of Danone's biotics portfolio alongside probiotics, prebiotics, and synbiotics.
• Specialized Hypoallergenic Formulas Including extensively hydrolyzed formulas (eHF) and amino acid-based formulas that offer crucial support to infants with severe cow's milk allergy (CMA), providing complete nutrition while reducing allergic risks.
• Akkermansia muciniphila MucT Next-generation probiotic supplement derived from Akkermansia muciniphila MucT bacterium. Clinical studies show it helps with weight loss maintenance and improves insulin sensitivity in adults with overweight or obesity.

Quantifiable outcome

• 200+ scientific publications and congress abstracts annually from robust clinical research
• +5 more outcomes

Named customers5 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Partnerships

15 partnerships are on record, tiered core, major and minor.

• Netherlands Organisation for Applied Scientific Research (TNO)coreStrategic or Co-development PartnerLong-standing collaboration spanning more than two decades on advanced digestive models. TNO and Danone jointly developed the TIM-1 (TNO Intestinal Model) for replicating the human upper GI tract, and Tiny TIM for infant digestive simulation. These tools enable research into nutrient absorption, digestion, and infant formula behavior.
• Utrecht University and University Medical Center UtrechtcoreStrategic or Co-development PartnerLeading academic collaboration in immunology research, advancing knowledge in how nutrition supports immune balance and resilience. Part of Danone's broader commitment to biotics and immune health research across life stages.
• California Polytechnic State University, Arizona State University, Yale School of Medicine, University of ArkansasmajorStrategic or Co-development PartnerAcademic collaboration for cross-sectional hydration study published in The Journal of Nutrition, examining the relationship between parent and child hydration habits in 729 parent-child pairs from Northwest Arkansas and Phoenix, Arizona.
• University of WageningencoreStrategic or Co-development PartnerLong-standing research partnership focused on plant-based protein properties and functionality. Collaboration has resulted in 40 publications in reputable journals and 6 doctoral theses, deepening scientific understanding of plant proteins in food systems.
• Maastricht UniversitymajorStrategic or Co-development PartnerLed a landmark double-blind, placebo-controlled clinical trial on pasteurized Akkermansia muciniphila MucT, published in Nature Medicine, demonstrating its efficacy for weight loss maintenance and insulin sensitivity improvement in adults with overweight or obesity.
• NWO Domain Applied Engineering Sciences (EARLYFIT Project)majorStrategic or Co-development PartnerCollaborative project between NWO and Danone to identify molecular markers underlying the interaction between nutrition, intestinal microbiome, and immune fitness in early life. Partly funded the PRESTO multicenter clinical trial on synbiotic supplementation in infants with cow's milk allergy.
• University of California San Diego (THDMI)coreStrategic or Co-development PartnerCo-founded the Human Diets & Microbiome Initiative (THDMI), a global collaboration to decode the complexity of gut microbiomes across diverse populations through advanced sequencing and data analysis, aiming to develop personalized nutritional solutions.
• KK Women's and Children's Hospital (KKH), SingaporemajorStrategic or Co-development PartnerJoint development of the Growth Tracker application for monitoring children's growth and development. KKH, the largest children's hospital in Singapore, collaborated with Danone to create a tool accessible to both parents and clinicians for tracking height and weight over time.
• Clinical Experts from Austria, UK, US, Turkey, and The NetherlandsmajorStrategic or Co-development PartnerMultidisciplinary clinical collaboration for comprehensive systematic review on human milk feeding in inherited metabolic disorders, examining over 50 studies to investigate the role of human milk feeding in infants with IMDs including phenylketonuria.
• Wageningen UniversitycoreStrategic or Co-development PartnerPartnership in biotics research advancing next-generation probiotic development, live biotherapeutic solutions, and microbiome science. Contributing to Danone's exploration of prebiotic and synbiotic formulations for personalized nutrition.
• Grand Défi Ferments du FuturmajorStrategic or Co-development PartnerStrategic research partnership exploring novel health applications and optimization of probiotic strains through integration of digital modeling and bioinformatics, advancing the science of next-generation biotics.
• Smart Protein Project and LetsProseedmajorStrategic or Co-development PartnerEuropean research initiatives focused on alternative protein development, sustainable food systems, and protein diversification. Danone participates to create protein-rich solutions with reduced environmental footprint as part of its commitment to sustainable nutrition.
• Startups (Mista Biomass Hack)minorStrategic or Co-development Partner2024 collaboration with startups working in biomass fermentation through the Mista Biomass Hack, developing prototypes using ingredients derived from biomass to accelerate commercialization of alternative proteins.
• Oncology Tech CompanymajorStrategic or Co-development PartnerPartnership with a leading oncology technology company to develop a nutrition module that screens for cancer-related malnutrition, an often-overlooked condition affecting up to 70% of cancer patients.
• NGOs and Local Healthcare SystemsmajorStrategic or Co-development PartnerPartnerships with non-governmental organizations and local healthcare systems to deploy the Iron Tracker in large-scale campaigns across Asia, Africa, and the Middle East, screening children for iron deficiency anemia and connecting them with iron-fortified nutritional solutions.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• DSM-Firmenich: Global ingredient and nutrition powerhouse with major R&D in vitamins, premixes, omega-3s, and biotics. Comparable in nutrition science R&D scale and commercial translation, but with a broader portfolio than Danone's internal focus.
• Kerry Group: Global taste and nutrition company with strong R&D in bioactives, probiotics, and functional ingredients for food and beverage. Comparable in applied nutrition science but broader in taste and food systems.
• International Flavors & Fragrances (IFF): Major ingredient supplier with Health & Biosciences division spanning probiotics, enzymes, and microbial cultures. Comparable in probiotic R&D and supply to nutrition brands, but operates as a broader ingredient portfolio.

Direct peers

• Chr. Hansen (now Novonesis): Global leader in microbial and fermentation solutions, including probiotic strains for food, nutrition, and infant formula. Direct competitor in the biotics and cultures ingredient space that Danone R&I develops internally.
• BioGaia: Swedish probiotic company developing proprietary Lactobacillus and Bifidobacterium strains for infant nutrition, gut health, and immune health. Closely comparable in biotic strain R&D and clinical evidence generation.
• Probi: Swedish probiotic R&D company focused on clinically validated Lactobacillus strains for gut health, immune health, and stress/mood applications. Direct comparable in proprietary probiotic strain development and clinical evidence.
• Lesaffre: French family-owned global yeast and fermentation company with growing activity in probiotics, microbiome science, and precision fermentation. Direct competitor in biotics and fermentation-derived ingredients.
• Nestlé Research: Internal R&D division of Nestlé, the world's largest food company; covers nutrition science, gut health, plant-based products, and personalized nutrition. Direct competitor to Danone R&I in scope, scale, and parent-company model.

Emerging players

• AB-Biotics: Spanish probiotic company developing proprietary strains for neurological, gastrointestinal, and women's health applications. Comparable in clinically validated probiotic strain development with a smaller scale.

Regional players

• Yili Group R&D: R&D arm of China's largest dairy company, with significant internal research on probiotics, infant formula, and dairy biotechnology. Comparable in internal-corporate R&D model and biotic strain focus, but primarily Asia-focused.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@danoneresearchinnovation
• LinkedInlinkedin.com/company/danoneresearch

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Danone Research & Innovation